Adverse events985

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 985

Type	Event	Organ system	Group	Affected	At risk	Events
other	Abdominal distension	Gastrointestinal disorders	Phase I:Dose Escalation Cohort; Arm 1:Phase I:DoseLevel 1: 1 x 10^9 E7 T-Cell Receptor (TCR) Cells	0	3	0
other	Abdominal distension	Gastrointestinal disorders	Phase I: Dose Escalation Cohort; Arm 1: Phase I; Dose Level 2: 1 x 10^10 E7 T-Cell Receptor Cells	0	3	0
other	Abdominal distension	Gastrointestinal disorders	Phase I: Dose Escalation Cohort; Arm 1: Phase I; Dose Level 3: 1 x 10^11 E7 Cells	1	6	2
other	Abdominal distension	Gastrointestinal disorders	Phase II Cohort; Arm 2: Phase II: 1 x 10^11 E7 Cells	3	18	4
other	Abdominal distension	Gastrointestinal disorders	Participants Enrolled But Were Not Treated	0	0	0
other	Abdominal pain	Gastrointestinal disorders	Phase I:Dose Escalation Cohort; Arm 1:Phase I:DoseLevel 1: 1 x 10^9 E7 T-Cell Receptor (TCR) Cells	1	3	1
other	Abdominal pain	Gastrointestinal disorders	Phase I: Dose Escalation Cohort; Arm 1: Phase I; Dose Level 2: 1 x 10^10 E7 T-Cell Receptor Cells	0	3	0
other	Abdominal pain	Gastrointestinal disorders	Phase I: Dose Escalation Cohort; Arm 1: Phase I; Dose Level 3: 1 x 10^11 E7 Cells	3	6	3
other	Abdominal pain	Gastrointestinal disorders	Phase II Cohort; Arm 2: Phase II: 1 x 10^11 E7 Cells	2	18	4
other	Abdominal pain	Gastrointestinal disorders	Participants Enrolled But Were Not Treated	0	0	0
other	Acidosis	Metabolism and nutrition disorders	Phase I:Dose Escalation Cohort; Arm 1:Phase I:DoseLevel 1: 1 x 10^9 E7 T-Cell Receptor (TCR) Cells	0	3	0
other	Acidosis	Metabolism and nutrition disorders	Phase I: Dose Escalation Cohort; Arm 1: Phase I; Dose Level 2: 1 x 10^10 E7 T-Cell Receptor Cells	0	3	0
other	Acidosis	Metabolism and nutrition disorders	Phase I: Dose Escalation Cohort; Arm 1: Phase I; Dose Level 3: 1 x 10^11 E7 Cells	1	6	1
other	Acidosis	Metabolism and nutrition disorders	Phase II Cohort; Arm 2: Phase II: 1 x 10^11 E7 Cells	0	18	0
other	Acidosis	Metabolism and nutrition disorders	Participants Enrolled But Were Not Treated	0	0	0
other	Activated partial thromboplastin time prolonged	Investigations	Phase I:Dose Escalation Cohort; Arm 1:Phase I:DoseLevel 1: 1 x 10^9 E7 T-Cell Receptor (TCR) Cells	0	3	0
other	Activated partial thromboplastin time prolonged	Investigations	Phase I: Dose Escalation Cohort; Arm 1: Phase I; Dose Level 2: 1 x 10^10 E7 T-Cell Receptor Cells	0	3	0
other	Activated partial thromboplastin time prolonged	Investigations	Phase I: Dose Escalation Cohort; Arm 1: Phase I; Dose Level 3: 1 x 10^11 E7 Cells	0	6	0
other	Activated partial thromboplastin time prolonged	Investigations	Phase II Cohort; Arm 2: Phase II: 1 x 10^11 E7 Cells	1	18	1
other	Activated partial thromboplastin time prolonged	Investigations	Participants Enrolled But Were Not Treated	0	0	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02858310/events

API reference For AI assistants

Adverse events985

Sources 3

Read this list from software.